Drugs / Ad5-nCoV-IM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05330871 | Apr → Jun 2022 | COVID-19 | Seventh Medical Center of PLA General Hospital | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ad5-nCoV-IM | “Ad5-nCoV-IM, 1 dose 0.3ml” NCT05330871 ↗ |
| Known as | IMAd5 | “intramuscular Ad5-nCoV vaccine (IMAd5; 0·3 mL)” PMID 37209700 ↗ May 2023 |
| Modality | Vaccine | “Ad5 COVID-19 Vaccines” NCT05330871 ↗ |
| Route | Intramuscular | “0.3ml intramuscular Ad5-nCoV-IM” NCT05330871 ↗ |